Innovating Works

HPSJ

RealCare: Real-time biomarker detection systems for rapid medical decision-making in cancer and cardiac diseas... FONDATION HOPITAL SAINT JOSEPH participó en un HORIZON EUROPE: HORIZON-HLTH-2023-TOOL-05 RealCare is a cutting-edge research initiative focused on developing and validating next-generation point-of-care (PoC) systems that detect...
2023-11-17 - 2028-11-30 | Financiado
PREVALUNG EU: Biomarkers affecting the transition from cardiovascular disease to lung cancer: towards stratified i... FONDATION HOPITAL SAINT JOSEPH participó en un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02 Cardiovascular disease (CVD) and lung cancer (LC) are leading causes of deaths and intertwined chronic inflammatory processes associated wit...
2022-11-24 - 2027-11-30 | Financiado
PAPA-ARTIS: Paraplegia Prevention in Aortic Aneurysm Repair by Thoracoabdominal Staging with Minimally Invasive... FONDATION HOPITAL SAINT JOSEPH participó en un H2020: H2020-SC1-2016-2017 Chronic aortic aneurysms are permanent and localized dilations of the aorta that remain asymptomatic for long periods of time but continue t...
2016-12-12 - 2024-09-30 | Financiado
SATURN: Impact of Specific Antibiotic Therapies on the prevalence of hUman host ResistaNt bacteria FONDATION HOPITAL SAINT JOSEPH participó en un FP7: Many results drawn from previous studies of the effect of antibiotic use on emergence, selection and spread of antimicrobial resistance (AMR...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.